博拓生物：关于变更保荐代表人的公告

Core Viewpoint - Botao Bio announced the appointment of Dai Qi as the new sponsor representative for its ongoing supervision during the IPO process on the Sci-Tech Innovation Board, following a personnel change due to personal reasons of the previous representative [2] Group 1 - Botao Bio's IPO process is being supervised by Guotai Junan Securities, with the supervision period lasting until December 31, 2024 [2] - The company has not yet fully utilized the funds raised from the IPO, prompting continued oversight of the fund's storage and usage [2] - Dai Qi, the newly appointed sponsor representative, possesses substantial investment banking experience and is deemed capable of fulfilling the supervisory responsibilities [2]